Sun, L., Quan, H., Xie, C., Wang, L., Hu, Y., & Lou, L. (2014). Phosphodiesterase 3/4 Inhibitor Zardaverine Exhibits Potent and Selective Antitumor Activity against Hepatocellular Carcinoma Both In Vitro and In Vivo Independently of Phosphodiesterase Inhibition. Public Library of Science.

Sun, Liping, Haitian Quan, Chengying Xie, Lei Wang, Youhong Hu, and Liguang Lou. Phosphodiesterase 3/4 Inhibitor Zardaverine Exhibits Potent and Selective Antitumor Activity against Hepatocellular Carcinoma Both In Vitro and In Vivo Independently of Phosphodiesterase Inhibition. Public Library of Science, 2014.

Sun, Liping, et al. Phosphodiesterase 3/4 Inhibitor Zardaverine Exhibits Potent and Selective Antitumor Activity against Hepatocellular Carcinoma Both In Vitro and In Vivo Independently of Phosphodiesterase Inhibition. Public Library of Science, 2014.